Rift Valley Fever: Next Generation Vaccines For An Old Foe,
2012
Viral Special Pathogens Branch Centers for Disease Control and Prevention
Rift Valley Fever: Next Generation Vaccines For An Old Foe, Brian Bird
Vaccine Technology IV
No abstract provided.
Leishmaniasis Vaccine Development: Animals As Models And Patients,
2012
IDRI
Leishmaniasis Vaccine Development: Animals As Models And Patients, Steven Reid
Vaccine Technology IV
No abstract provided.
Biomechanical Testing On Cadaveric Spines For Different Treatments That Affect Lumbar Stability,
2012
University of South Florida
Biomechanical Testing On Cadaveric Spines For Different Treatments That Affect Lumbar Stability, Sabrina Alejandra Gonzalez Blohm
USF Tampa Graduate Theses and Dissertations
Stenosis is one of the most common causes for spinal surgery. Laminectomy decompression and fusion are surgical procedures prescribed for this condition. The intention of this work was to investigate the effects of a laminectomy decompression, followed by fusion, on a lumbar functional spinal unit (FSU) through in vitro dynamic (±8Nm at 0.125Hz) and quasi-static (±7.5Nm at 0.1Hz) biomechanical tests, for flexion, extension, bending and rotation motions.
Six FSUs where disarticulated from four human cadaveric lumbar spines (63 ± 12 years) and were tested under the following sequence: (1) intact, (2) laminectomy decompression, and (3) Pedicle Screw System (PSS), using …
Conference Program,
2012
Engineering Conferences International
Conference Program, Engineering Conferences International
Vaccine Technology IV
No abstract provided.
Tolerogenic Vaccination Exploiting Apoptotic Mechanisms Via Erythrocyte-To- Hepatic/Splenic Targeting,
2012
Institute of Bioengineering, EPFL
Tolerogenic Vaccination Exploiting Apoptotic Mechanisms Via Erythrocyte-To- Hepatic/Splenic Targeting, Jeffrey Hubbell
Vaccine Technology IV
No abstract provided.
Bringing Vaccine Manufacturing Capabilities To The Developing World,
2012
PATH
Bringing Vaccine Manufacturing Capabilities To The Developing World, George Robertson
Vaccine Technology IV
No abstract provided.
Rabies Virus-Like Particles Expressed In Hek293 Cells,
2012
Cell Culture Laboratory Biochemistry and Biological Sciences School Universidad Nacional del Litoral Santa Fe - Argentina
Rabies Virus-Like Particles Expressed In Hek293 Cells, Diego Fontana, Ricardo Kratje, Marina Etcheverrigaray, Claudio Prieto
Vaccine Technology IV
No abstract provided.
Expectation Of China's Contribution To World Vaccine Development And Supplies: Status, Strategy And International Approach,
2012
Shanghai Zerun Biotechnology
Expectation Of China's Contribution To World Vaccine Development And Supplies: Status, Strategy And International Approach, Li Shi
Vaccine Technology IV
No abstract provided.
Process Understanding Approach For A Late-Stage Recombinant Protein Vaccine Produced In Saccharomyces Cerevisiae,
2012
Vaccine Process Development, Merck & Co
Process Understanding Approach For A Late-Stage Recombinant Protein Vaccine Produced In Saccharomyces Cerevisiae, Jose Manuel Otero, Brian Mickus, Amanda Schallop, Brian Doyle, Nedim Altaras
Vaccine Technology IV
No abstract provided.
Challenges In Development Of An Anti-Idiotypic Cancer Vaccine,
2012
Centro de Inmunlogia Molecular
Challenges In Development Of An Anti-Idiotypic Cancer Vaccine, Adolfo Castillo
Vaccine Technology IV
No abstract provided.
The Role Of Public-Private Partnerships In Advancing Vaccine Technologies And Improving Vaccine Effectiveness And Delivery For Developing Countries, Ray Cummings
Vaccine Technology IV
No abstract provided.
Challenges In Batch Production Of Malaria Vaccines,
2012
European Vaccine Initiative
Challenges In Batch Production Of Malaria Vaccines, Nicolas Havelange
Vaccine Technology IV
No abstract provided.
Establishing Human Vaccine Manufacturing In Southern Africa,
2012
The Biovac Institue
Establishing Human Vaccine Manufacturing In Southern Africa, Morena Makhoana
Vaccine Technology IV
No abstract provided.
Rational Design Of A Fully Synthetic Nanoparticle-Based Vaccine For Smoking Cessatio,
2012
Selecta Biosciences
Rational Design Of A Fully Synthetic Nanoparticle-Based Vaccine For Smoking Cessatio, Takashi Kishimoto
Vaccine Technology IV
No abstract provided.
Recombinant Vlp Based Human Vaccines For Emerging Markets,
2012
School of Public Health, Xiamen University
Recombinant Vlp Based Human Vaccines For Emerging Markets, Qinjian Zhao
Vaccine Technology IV
No abstract provided.
111 Years Producing Immunobiologicals: New Challenges,
2012
Instituto Butantan
111 Years Producing Immunobiologicals: New Challenges, Jorge Kalil
Vaccine Technology IV
No abstract provided.
Development Of A Vaccine Against Clostridium Difficile Infection (Cdi): Design, Purification, And Biological Activities Of The Recombinant Toxin 1 Antigens,
2012
Merck Research Laboratories, Vaccine Basic Research
Development Of A Vaccine Against Clostridium Difficile Infection (Cdi): Design, Purification, And Biological Activities Of The Recombinant Toxin 1 Antigens, Jerzy Karczewski
Vaccine Technology IV
No abstract provided.
Recombinant Influenza Vaccine,
2012
Protein Sciences Corporation
Computational Design And Characterization Of A Temperature-Sensitive Plasmid Replicon For Gram Positive Thermophiles,
2012
Dartmouth College
Computational Design And Characterization Of A Temperature-Sensitive Plasmid Replicon For Gram Positive Thermophiles, Daniel G. Olson, Lee R. Lynd
Dartmouth Scholarship
Temperature-sensitive (Ts) plasmids are useful tools for genetic engineering, but there are currently none compatible with the gram positive, thermophilic, obligate anaerobe, Clostridium thermocellum. Traditional mutagenesis techniques yield Ts mutants at a low frequency, and therefore requires the development of high-throughput screening protocols, which are also not available for this organism. Recently there has been progress in the development of computer algorithms which can predict Ts mutations. Most plasmids currently used for genetic modification of C. thermocellum are based on the replicon of plasmid pNW33N, which replicates using the RepB replication protein. To address this problem, we set out …
Development Of A Multiple Contact Haptic Display With Texture-Enhanced Graphics,
2012
Virginia Commonwealth University
Development Of A Multiple Contact Haptic Display With Texture-Enhanced Graphics, David Burch
Theses and Dissertations
This dissertation presents work towards the development of a multiple finger, worn, dynamic display device, which utilizes a method of texture encoded information to haptically render graphical images for individuals who are blind or visually impaired. The device interacts directly with the computer screen, using the colors and patterns displayed by the image as a means to encode complex patterns of vibrotactile output, generating the texture feedback to render the image. In turn, the texture feedback was methodically designed to enable parallel processing of certain coarse information, speeding up the exploration of the diagram and improving user performance. The design …
